HCM
CDLX icon

Highbridge Capital Management’s Cardlytics CDLX Stock Holding History

Highbridge Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,892
Closed -$4.13M – 120
2020
Q3 		$4.13M Buy
+5,892
New +$4.28M 0.22% 64

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Highbridge Capital Management's CDLX Position: Q4 2020 in Review

Highbridge Capital Management sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 5,892 shares — an estimated $4.13M sold.

Highbridge Capital Management first reported a position in CDLX in Q3 2020 and held it in 1 quarter. The position peaked at $4.13M in Q3 2020. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Highbridge Capital Management reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
  • Highbridge Capital Management sold 5,892 Cardlytics shares in Q4 2020, an estimated $4.13M.
  • Highbridge Capital Management first reported a position in Cardlytics in Q3 2020 and held it in 1 quarter.
  • Highbridge Capital Management's Cardlytics position peaked at $4.13M in Q3 2020.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Highbridge Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.